Why integrating behavioral health into cancer care matters for health plans

The overlooked role of behavioral health in oncology

Cancer treatment affects more than physical health — behavioral health needs can significantly influence outcomes, experience, and continuity of care. Anxiety, depression, and emotional distress are common during diagnosis, active treatment, and survivorship, yet they are often addressed separately from oncology care.

Evidence shows that approximately one‑third of people undergoing cancer treatment experience clinically significant distress or mental health conditions, but many do not receive timely or coordinated support. When these needs go unaddressed, the consequences can extend beyond patient well‑being to impact utilization patterns and total cost of care. 

How unaddressed behavioral health affects outcomes and utilization

For health plans, fragmented behavioral health support can quietly undermine cancer care in measurable ways. Research consistently links untreated distress in oncology populations to:

• Lower treatment adherence
• Delayed initiation or interruption of therapy
• Higher emergency department utilization
• Increased inpatient admissions and mortality risk

Internal analysis from the Evernorth Research Institute underscores the utilization impact of unaddressed behavioral health needs in oncology populations. Oncology patients who do not receive outpatient behavioral health support are twice as likely to experience avoidable emergency department visits compared to those who do, contributing to higher downstream medical utilization and cost. 

These patterns reinforce that behavioral health is not a peripheral consideration in cancer care — it is a population‑level driver of outcomes, experience, and total cost of care.

Why behavioral health remains fragmented in cancer care

Despite growing evidence, behavioral health often remains siloed from oncology treatment pathways. Common challenges include:

• Limited psychosocial screening or visibility early in the cancer journey
• Disconnected referral and care coordination workflows
• Inconsistent access to oncology‑informed behavioral health services
• Separate medical and behavioral benefit structures

For health plans, these gaps make it difficult to identify risk early, intervene consistently, and scale support across diverse oncology populations.

Integrated care models show measurable impact

Integrated oncology–behavioral health models are gaining momentum as evidence continues to link alignment across disciplines with more consistent outcomes. Recent research and clinical analyses associate more integrated approaches with improved adherence to cancer treatment, stronger patient engagement, and reductions in avoidable acute care utilization.

For example, a 2025 analysis published in the Journal of the National Comprehensive Cancer Network highlights that patients whose psychosocial needs are identified and addressed alongside oncology care are more likely to complete recommended treatment and experience better continuity of care. Similarly, integrated and collaborative care models have been linked to fewer emergency department visits and improved patient‑reported outcomes across complex medical populations, according to 2025 findings in The Journal of the American Board of Family Medicine. 

More recent oncology‑specific evaluations also underscore how embedding behavioral health support into cancer care pathways can reduce treatment disruption and improve overall engagement during emotionally intensive periods. Together, these findings suggest that when behavioral health is addressed proactively and in coordination with oncology care, health plans are better positioned to manage the clinical, emotional, and utilization complexity that defines modern cancer journeys. 

Addressing complexity across the cancer care journey

Cancer care is rarely linear. Members may experience:

• Multiple treatment modalities and providers
• Significant emotional, social, and financial stressors
• Long treatment timelines with varying intensity
• Transitions between active treatment, survivorship, or advanced care

Behavioral health needs can emerge at any stage — often intensifying during treatment changes or uncertainty. Without coordinated support, plans risk reacting after avoidable utilization has already occurred.

This complexity has increased focus on precision‑guided, whole‑person oncology approaches that align clinical and behavioral insights.

Advancing whole‑person oncology care through integration

As cancer care becomes more complex, health plans are increasingly recognizing the need to move beyond siloed approaches to oncology and behavioral health. Integrated care models that align clinical, behavioral, and care coordination capabilities can play an important role in addressing the full spectrum of needs that emerge throughout the cancer journey.

By bringing behavioral health insights into oncology pathways, these approaches aim to help plans identify psychosocial risk earlier, coordinate care more effectively across disciplines, and improve the experience for members navigating intensive and emotionally demanding treatment. For plans managing rising oncology costs and growing member complexity, integrated models offer an opportunity to create greater clarity, continuity, and consistency across cancer care delivery — while supporting outcomes that are aligned to long‑term value.

Moving toward whole‑person oncology strategies

The evidence is clear: behavioral health plays a meaningful role in cancer outcomes, experience, and cost. For health plans, integration is no longer simply a clinical consideration — it is a strategic lever.

As oncology care continues to evolve, plans that align behavioral health with cancer care are better positioned to support members, manage utilization, and deliver more connected, whole‑person care.

Originally published on 2/5/2025 and updated on 5/7/2026.